These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 36682332)

  • 1. Deubiquitinating enzyme YOD1 deubiquitinates and destabilizes α-synuclein.
    Park SS; Do HA; Park HB; Choi HS; Baek KH
    Biochem Biophys Res Commun; 2023 Feb; 645():124-131. PubMed ID: 36682332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effect of YOD1 and USP21 on the Hippo signaling pathway.
    Park SS; Baek KH
    Cancer Cell Int; 2023 Sep; 23(1):209. PubMed ID: 37743467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UL36 Encoded by Marek's Disease Virus Exhibits Linkage-Specific Deubiquitinase Activity.
    Lin J; Ai Y; Zhou H; Lv Y; Wang M; Xu J; Yu C; Zhang H; Wang M
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32150874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteasome substrate receptors and their therapeutic potential.
    Osei-Amponsa V; Walters KJ
    Trends Biochem Sci; 2022 Nov; 47(11):950-964. PubMed ID: 35817651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deubiquitinase YOD1 suppresses tumor progression by stabilizing E3 ligase TRIM33 in head and neck squamous cell carcinoma.
    Wu Y; Duan Y; Han W; Cao J; Ye B; Chen P; Li H; Wang Y; Liu J; Fang Y; Yue K; Wu Y; Wang X; Jing C
    Cell Death Dis; 2023 Aug; 14(8):517. PubMed ID: 37573347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Ubiquitin-Proteasome System and Mitophagy in the Pathogenesis of Parkinson's Disease.
    Liang Y; Zhong G; Ren M; Sun T; Li Y; Ye M; Ma C; Guo Y; Liu C
    Neuromolecular Med; 2023 Dec; 25(4):471-488. PubMed ID: 37698835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DUB-le vision: snapshots of the proteasome during substrate processing.
    Schnell HM; Hanna J
    Trends Biochem Sci; 2022 Nov; 47(11):903-905. PubMed ID: 35963751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the ubiquitin pathway in lymphoid malignancies.
    Li B; Adam Eichhorn PJ; Chng WJ
    Cancer Lett; 2024 Jul; 594():216978. PubMed ID: 38795760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro-apoptotic and anti-apoptotic regulation mediated by deubiquitinating enzymes.
    Choi HS; Baek KH
    Cell Mol Life Sci; 2022 Feb; 79(2):117. PubMed ID: 35118522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical Roles of Deubiquitinating Enzymes in the Nervous System and Neurodegenerative Disorders.
    Das S; Ramakrishna S; Kim KS
    Mol Cells; 2020 Mar; 43(3):203-214. PubMed ID: 32133826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel insights into the role of ubiquitination in osteoarthritis.
    Lin Y; Jiang S; Su J; Xie W; Rahmati M; Wu Y; Yang S; Ru Q; Li Y; Deng Z
    Int Immunopharmacol; 2024 May; 132():112026. PubMed ID: 38583240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional and structural diversity in deubiquitinases of the Chlamydia-like bacterium Simkania negevensis.
    Boll V; Hermanns T; Uthoff M; Erven I; Hörner EM; Kozjak-Pavlovic V; Baumann U; Hofmann K
    Nat Commun; 2023 Nov; 14(1):7335. PubMed ID: 37957213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deubiquitylating enzymes and drug discovery: emerging opportunities.
    Harrigan JA; Jacq X; Martin NM; Jackson SP
    Nat Rev Drug Discov; 2018 Jan; 17(1):57-78. PubMed ID: 28959952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deubiquitinases in muscle physiology and disorders.
    Olie CS; O'Brien DP; Jones HBL; Liang Z; Damianou A; Sur-Erdem I; Pinto-Fernández A; Raz V; Kessler BM
    Biochem Soc Trans; 2024 Jun; 52(3):1085-1098. PubMed ID: 38716888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the Role of Ubiquitin-Proteasome System in the Pathogenesis of Parkinson's Disease.
    Zhao Y; Lin M; Zhai F; Chen J; Jin X
    Pharmaceuticals (Basel); 2024 Jun; 17(6):. PubMed ID: 38931449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Deubiquitylase Otub1 Regulates the Chemotactic Response of Splenic B Cells by Modulating the Stability of the γ-Subunit Gng2.
    Luo VM; Shen C; Worme S; Bhagrath A; Simo-Cheyou E; Findlay S; Hébert S; Wai Lam Poon W; Aryanpour Z; Zhang T; Zahedi RP; Boulais J; Buchwald ZS; Borchers CH; Côté JF; Kleinman CL; Mandl JN; Orthwein A
    Mol Cell Biol; 2024 Jan; 44(1):1-16. PubMed ID: 38270191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of deubiquitinases in cardiac disease.
    Zhan X; Yang Y; Li Q; He F
    Expert Rev Mol Med; 2024 Mar; 26():e3. PubMed ID: 38525836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cycad Genotoxin Methylazoxymethanol Disrupts the Brain Ubiquitin-Proteasome Pathway, Tau and α-Synuclein, as Reported in ALS-PDC.
    Kisby GE; Eriksen JL; Chlebowski AC; Spencer PS
    J Neuropathol Exp Neurol; 2021 Feb; 80(3):286-288. PubMed ID: 33550390
    [No Abstract]   [Full Text] [Related]  

  • 19. OTUB1 inhibits breast cancer by non-canonically stabilizing CCN6.
    Zhao Y; Ruan J; Li Z; Su X; Chen K; Lin Y; Cai Y; Wang P; Liu B; Schlüter D; Liang G; Wang X
    Clin Transl Med; 2023 Aug; 13(8):e1385. PubMed ID: 37608493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Yeast Chronological Lifespan Assay to Assess Activity of Proteasome Stimulators.
    Maresh ME; Chen P; Hazbun TR; Trader DJ
    Chembiochem; 2021 Aug; 22(15):2553-2560. PubMed ID: 34043860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.